FDA Clearance Tracker · K192028
Yumizen C1200 CRP
Last checked: Nov 19, 2026Latest source record: Jun 25, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2020
Substantially Equivalent
Time to decision
335 days
Received Jul 26, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192028
- Device name
- Yumizen C1200 CRP
- Applicant
- HORIBA ABX SAS
- Applicant location
- Montpellier Cedex 4, FR
- Received
- Jul 26, 2019
- Decided
- Jun 25, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5270
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DCK. The earliest in FDA's data is K760035, decided Aug 3, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192028
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for HORIBA ABX SAS
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Yumizen H550510(k)
K260781 · Decided Sep 14, 2026 · 188 days after receipt
Device type: Counter, Differential Cell (GKZ) · Laboratory Medicine & Pathology
- Yumizen H2500510(k)
K232946 · Decided May 21, 2024 · 244 days after receipt
Device type: Counter, Differential Cell (GKZ) · Laboratory Medicine & Pathology
K193649 · Decided May 10, 2021 · 497 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.